$NVCR

NovoCure Ltd

Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · St. Helier

NVCR chart

What traders are saying about $NVCR

Latest posts

NovoCure Ltd news

NovoCure Ltd key financials

USD2025202420232022
Revenue$655.4M$605.2M$509.3M$537.8M
Net income-$136.2M-$169.0M-$207.0M-$93.0M
Diluted EPS$-1.22$-1.56$-1.95$-0.88
Total assets (year end)$804.3M$1.24B$1.15B$1.19B
Cash and equivalents (year end)$93.5M$163.8M$240.8M$115.3M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About NovoCure Ltd

Ticker
NVCR (Nasdaq)
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
St. Helier
Fiscal year end
December 31
SEC CIK
1645113

Frequently asked questions

What exchange is NovoCure Ltd listed on?

NovoCure Ltd trades on the Nasdaq under the ticker symbol NVCR.

What industry is NovoCure Ltd in?

NovoCure Ltd is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.

Where is NovoCure Ltd headquartered?

NovoCure Ltd's business address on file with the SEC is in St. Helier.

When does NovoCure Ltd's fiscal year end?

NovoCure Ltd's fiscal year ends on December 31.

How much revenue did NovoCure Ltd report?

NovoCure Ltd reported $655.4M in revenue for calendar year 2025, according to its SEC filings.